Market Signal Briefing

Cryptocurrencies continued to dump on Friday as Bitcoin dipped below $109,000 and Ethereum fell under $3,900. The global crypto market capitalization shrank 2% to $3.74 trillion as most coins inched towards oversold territory and liquidations rose. While Solana, XRP and BNB wavered, altcoins like Mantle, Hyperliquid, and Aethir bucked the trend, posting impressive gains.

The cryptocurrency market was a sea of red after a brutal week left traders reeling as major cryptocurrencies traded in bearish territory. The drop has pushed the market into negative territory for September, although Bitcoin (BTC) is holding on to a 1% gain for the month. The markets have shed over 2% in the past 24 hours, with the market cap down to $3.75 trillion. 

BTC slumped to a four-week low as selling pressure intensified. The flagship cryptocurrency fell to an intraday low of $108,776 before registering a marginal recovery and reclaiming $109,000. BTC is down over 2% during the ongoing session, trading around $109,393, with sellers in control. 

Ethereum (ETH) slumped below the key $4,000 mark and is down nearly 3%, trading around $3,910. Ripple (XRP) is down almost 4%, trading around $2.75, while Solana (SOL) lost the key $200 level and is trading around $195, down over 5%. Dogecoin (DOGE) is down 4%, while Cardano (ADA) is down 3%, trading around $0.772. Chainlink (LINK), Stellar (XLM), Hedera (HBAR), Litecoin (LTC), Toncoin (TON), and Polkadot (DOT) also registered notable declines over the past 24 hours. 

TeraWulf Planning $3B Debt-Finance Expansion Google-backed crypto miner TeraWulf plans to raise around $3 billion to expand its data centers. TeraWulf's finance head, Patrick Fleury, stated that Google is supporting the deal. The debt will be issued through the high-yield bond market or leveraged loans. Morgan Stanley is overseeing the transaction, which could be executed as early as October. The deal is also being reviewed by credit rating agencies, with expectations it will land between BB and CCC, the typical range for junk-rated debt. However, Google’s support could help secure a higher grade. 

TeraWulf’s push comes amid growing demand for artificial intelligence infrastructure, which has outstripped supply. AI’s rapid growth has created a severe crunch of data center space, graphics processing chips, and electricity access. Mining firms like TeraWulf that operate large-scale facilities have become attractive partners for companies looking to expand into AI computing. 

Tokenized TradFi Assets Will Redefine Crypto Sergey Nazarov, the co-founder of Chainlink Labs, believes the path towards tokenizing the financial system is now clear with Paul Atkins as the Chair of the United States Securities and Exchange Commission (SEC). Nazarov believes it will not be an easy task as there are various challenges regarding the tokenization of data, cross-chain connectivity, compliance, and several other areas. However, he stated that the consequences of tokenizing TradFi assets could be revolutionary. Nazarov stated, 

“What people don’t fully appreciate about TradFi [traditional finance] is its sheer scale.”

Nazarov credited President Donald Trump for ushering in the global acceptance of crypto and tokenization of assets, adding that regulators warned investors to stay away from crypto during previous administrations.

 “Don’t touch this stuff; it’s illegal. But now regulators are saying, ‘Not only is it not illegal, we want you to do it. So, the movement of significant amounts of TradFi assets on-chain seems inevitable, as long as the macroeconomy doesn’t crater.”

According to Nazarov, a cratering of the economy could happen if it moves from a risk-on to a risk-off environment. However, he believes tokenization will occur despite the downturn. 

“All these new tokenized assets need an active market where people want to try new things, trade, and deploy capital into new instruments. Right now, the conditions are positive: Interest rates are expected to be cut, and the SEC chairman is making speeches about how everything will be tokenized. I can’t imagine a more positive scenario.”

Nazarov also believes Trump has delivered on his promise of being the “crypto president.”

“We were already having meetings with the SEC early in the year. I’d say she already had a green light to start doing things early in the year. So, a lot of work was already underway, and then, it became more public once it was clear who the chairman would be. At that point, risk and doubt were removed from the equation.”

MSTR Stock In Trouble Strategy’s (MSTR) stock price fell below a key support level as BTC crashed below $110,000 and its mNAV multiple fell to a year-to-date low. MSTR fell to $297 on Thursday, its lowest level since April, and 35% below its all-time high. The crash brought its market capitalization from $129 billion to $84 billion. The stock has plunged due to the ongoing crypto market crash, with BTC falling below $110,000 for the first time since September 1. Analysts highlighted that it has formed a head-and-shoulders pattern, indicating further downside in the near term. Meanwhile, BTC has formed a rising wedge on its weekly chart, suggesting markets could be witnessing the start of prolonged bearish sentiment. 

A prolonged bear market could spell trouble for Strategy and its stock price. The company has established itself as the largest corporate holder of Bitcoin, holding 639,835 BTC, valued at $69 billion at current prices. BTC’s decline means that Strategy's premium has also plunged. Strategy’s mNAV has also dropped to a year-to-date low of 1.195. A falling mNAV is risky because Strategy uses its premium to raise capital and fund Bitcoin purchases. 

Bitcoin (BTC) Price Analysis Bitcoin (BTC) has wiped out nearly all of its monthly gains after a brutal week dragged the price below the key $110,000 level. The flagship cryptocurrency has faced substantial selling pressure all week, starting with Monday’s flash crash. Buyers attempted a recovery on Wednesday as the price rose above $113,000 and settled at $113,348. However, selling pressure returned on Thursday as BTC plunged almost 4%, slipping below $110,000 and settling at $109,035. The current session sees the price up 0.49%, trading around $109,585. 

On-chain analysis shows that BTC could be headed for a deeper correction as cumulative realised long-term holder profit-taking is reaching levels seen during previous cycle tops. According to the analysis, long-term BTC holders realized 3.4 million BTC in profit. ETF inflows have also slowed, indicating exhaustion following the Federal Reserve’s rate cut last week. The flagship cryptocurrency fell below key support levels on Thursday, briefly dropping below $109,000 on Coinbase late Thursday before rebounding. Analysts fear bears could drag prices even lower, with the rebound quickly losing momentum. 10x Research head Markus Thielen stated, 

“The bounce back from that dip quickly lost momentum, and with prices now hovering close to this level again, another wave of stop-loss selling could emerge. This comes at a time when many are positioned for a Q4 rally — making the bigger surprise not a surge higher, but a correction instead.”

Meanwhile, Glassnode analysts believe BTC could be heading for a cooling phase. Glassnode stated that the realized profit/loss ratio shows that profit-taking has crossed 90% of coins moved three times this cycle, and markets have just stepped away from the third such extreme. 

“Historically, these peaks have marked major cycle tops, and probabilities favor a cooling phase ahead.”

Thielen also pointed out that the Spent Output Profit Ratio (SOPR) is showing concerning behavior, with some BTC holders beginning to sell at a loss, indicating significant market stress. However, buyers are stepping in, with the aggregate spot orderbook bid-ask ratio tilting towards buyers. The aggregate spot orderbook bid-ask ratio measures the relationship between the number of buy orders (bids) and sell orders (asks) in an order book. 

“A bid/ask ratio that is greater than 0 indicates that there are more buy orders than sell orders in the order book, which could suggest that there is greater demand for the asset at the current price level.”

BTC ended the previous weekend in the red, dropping 0.56% and settling at $115,314. The price faced volatility on Monday as buyers and sellers struggled to establish control. Buyers ultimately gained the upper hand as BTC registered a marginal increase and settled at $115,381. Bullish sentiment intensified on Tuesday as the price rose 1.26% to cross $116,000 and settle at $116,832. Selling pressure returned on Wednesday as BTC fell to an intraday low of $114,724. It recovered from this level to settle at $116,484, ultimately dropping 0.30%. BTC reached an intraday high of $117,998 on Thursday. However, it could not stay at this level and settled at $117,117. The price lost momentum on Friday, dropping 1.22% to $115,690.

Source: TradingView

Price action was mixed over the weekend, with BTC registering a marginal increase on Saturday. However, it was back in the red on Sunday, dropping 0.41% to $115,282. The flagship cryptocurrency plunged to an intraday low of $111,761 on Monday as bearish sentiment intensified. It recovered from this level to reclaim $112,000 and settle at $112,736. Buyers attempted a recovery on Tuesday as BTC reached an intraday high of $113,357. However, it failed to stay at this level and settled at $112,017, ultimately dropping 0.64%. The price fell to an intraday low of $111,066 on Wednesday as selling pressure intensified. Despite the bearish sentiment, it recovered to register a 1.19% increase and settle at $113,348. Bearish sentiment intensified on Thursday as BTC plunged nearly 4%, slipping below $110,000 and settling at $109,035. The current session sees BTC up 0.51%, trading around $109,598, as buyers look to reclaim the crucial $110,000 level.

Ethereum (ETH) Price AnalysisEthereum (ETH) fell below the key $4,000 level on Thursday as selling pressure dragged prices lower. The altcoin has struggled to regain momentum after Monday’s crash and dropped to $4,155 by Wednesday. Selling pressure returned on Thursday as ETH fell almost 7%, slipping below $4,000 to $3,876. The price has recovered during the ongoing session, up 1.62% to $3,962.

Meanwhile, Ethereum ETFs suffered another day of outflows, losing over $250 million after registering the fourth consecutive day of outflows. According to data from SoSoValue, the bulk of the outflows were from Fidelity’s FETH fund, which registered $158 million in outflows. The substantial outflows highlight the growing bearish sentiment around ETH ETFs. Grayscale’s ETHE and Bitwise’s ETHW registered outflows of $30 million and $27 million, respectively. Meanwhile, VanEck’s ETHV saw outflows of $1.4 million. The withdrawals are the largest single-day redemption this week, and take total outflows for the week past $540 million.

The substantial outflows have compounded ETH’s price struggles, with ETH dropping below the $4,000 mark. The altcoin has fallen nearly 15% over the past week, with the consistent downward trend erasing a substantial portion of recent gains.

ETH ended the previous weekend in the red, dropping 1.27% and settling at $4,608. Sellers retained control on Monday as the price fell nearly 2%, slipping below $4,600 and settling at $4,527. ETH dropped 0.55% on Tuesday, settling at $4,502. Despite the overwhelming selling pressure, the price recovered on Wednesday, rising 1.99% and settling at $4,591. However, it was back in the red on Thursday, registering a marginal decline and settling at $4,589. Selling pressure intensified on Friday as ETH fell 2.58%, slipping below $4,500 and settling at $4,471.

Source: TradingView

ETH registered a marginal recovery on Saturday but was back in the red on Sunday, dropping 0.73% to $4,449. Selling pressure intensified on Monday as ETH started the week in bearish territory. As a result, it fell nearly 6%, falling to an intraday low of $4,083 before settling at $4,202. Sellers retained control on Tuesday as ETH fell almost 1% to $4,166. ETH registered a marginal decline on Wednesday after buyers lost momentum, dropping to $4,155. Bearish sentiment intensified on Thursday as the price fell nearly 7%, slipping below $4,000 to $3,876. The price has recovered during the ongoing session, and is up 1.38%, trading around $3,930.

Solana (SOL) Price AnalysisSolana (SOL) has registered a marginal recovery during the ongoing session as it looks to reclaim the crucial $200 level. The altcoin faced tremendous selling pressure over the week, plunging nearly 7% on Monday and dropping to a low of $205 on Wednesday. Bearish sentiment intensified on Thursday as SOL fell almost 9%, slipping below $200 to $192. SOL is trading around $194 during the ongoing session.

SOL’s MACD reveals extreme bearish sentiment, with analysts stating prices could go below $190. The altcoin has dropped nearly 20% over the past week, erasing all of the gains made during its ascent to $253.

However, a key spot ETF ruling could change the narrative around SOL. Grayscale’s spot Solana ETF is set for its first approval deadline on October 12. The decision could unlock institutional capital flows to SOL, similar to what we have seen with BTC and ETH over the past year. The REX Osprey Staking SOL ETF already offers investors exposure to SOL. However, its structure is less significant than a pure spot product. On the other hand, a Grayscale spot ETF will allow direct institutional participation, unlocking deeper liquidity and broader adoption.

The SEC is also set to review five other ETF applications, with a final ruling due on October 16. These include ETF proposals from Bitwise, 21Shares, VanEck, Grayscale, and Canary.

Solana (SOL) reached an intraday high of $249 on Sunday (September 14). However, it could not stay at this level and settled at $240, dropping 0.99%. Selling pressure intensified on Monday as the price fell by over 2% to $234. Despite the overwhelming selling pressure, SOL recovered on Tuesday, rising 1.06% and settling at $226. Bullish sentiment intensified on Wednesday as the price rose over 3% to cross $240 and settle at $244. SOL reached an intraday high of $253 on Thursday. However, it could not stay at this level and settled at $247, ultimately rising 1.11%. Selling pressure returned on Friday as the price fell 3.59% to $238.

Source: TradingView

Price action was mixed over the weekend as SOL registered a marginal increase on Saturday before dropping 1.34% on Sunday and settling at $236. Bearish sentiment intensified on Monday as SOL fell nearly 7%, dropping to an intraday low of $214 before settling at $220. Sellers retained control on Tuesday as the price fell by over 3% and settled at $213. SOL fell almost 1% on Wednesday and settled at $211. Beamish sentiment intensified on Thursday as SOL plunged nearly 9%, falling from $200 to $192. The current session sees the price marginally down as buyers and sellers struggle to establish control.

Filecoin (FIL) Price AnalysisFilecoin (FIL) started the previous week in the red, dropping nearly 4% to 2.41. It recovered on Tuesday, reaching an intraday high of $2.66 before settling at $2.55, ultimately rising 5.99%. FIL faced volatility on Wednesday and Thursday as buyers and sellers struggled to gain control. Buyers ultimately gained the upper hand as the price rose marginally and settled at $2.57. Selling pressure returned on Friday as FIL fell almost 5% to $2.45.

Source: TradingView

Price action remained bearish over the weekend as FIL fell 0.39% on Saturday and nearly 2% on Sunday to $2.39. Bearish sentiment intensified on Monday as the price fell 5.99% to $2.25. Sellers retained control on Tuesday as FIL fell 0.56%. Buyers attempted a recovery on Wednesday as the price reached an intraday high of $2.28. However, it lost momentum after reaching this level and fell to $2.21. Selling pressure intensified on Thursday as FIL fell over 4% and settled at $2.11. The current session sees the price down 0.36% at $2.10.

Jupiter (JUP) Price AnalysisJupiter (JUP) started the previous weekend in bearish territory, dropping almost 6% on Friday and settling at $0.525. Price action was mixed over the weekend as JUP rose 0.42% on Saturday before dropping 1.19% on Sunday and settling at $0.521. Selling pressure intensified on Monday as the price fell by over 9% to $0.473.

Source: TradingView

Sellers retained control on Tuesday as JUP fell 1.89% and settled at $0.464. The price reached an intraday high of $0.484 on Wednesday as buyers and sellers struggled to take control. Buyers ultimately gained the upper hand as JUP rose 1.51% and settled at $0.471. Selling pressure returned on Thursday as the price fell almost 10% and settled at $0.426. JUP is marginally down during the ongoing session, trading around $0.427.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Dogecoin (CRYPTO: DOGE) has slumped 17% over the past week, but whale accumulation has sparked optimism for a rebound.

Trader Notes: Crypto chart analyst Ali Martinez said Dogecoin must hold above $0.22 to trigger a potential rally toward $0.29.

Daan Crypto Trades explained that Dogecoin's price action is a good representation of the broader crypto market over the past few months.

Since the April lows, many coins, especially majors like Bitcoin and Ethereum, have trended higher, though progress has been slow and uneven.

Dogecoin has been climbing gradually, posting slightly higher highs and higher lows, which technically confirms an uptrend but lacks strong momentum.

Most other altcoins haven't matched this consistency, instead swinging up and down in two-week cycles without meaningful gains.

The slow, steady structure in DOGE could serve as a strong base for future growth, but the sustainability of this trend depends on avoiding lower lows, which would undermine the current setup.

Statistics: Martinez highlighted that whales purchased 2 billion DOGE, worth $480 million, in 48 hours raising curiosity if it indicates any speculation on potential market movements.

Coinglass data shows DOGE liquidations hit $14.87 million in the past 24 hours, with $11.6 million in long positions closed amid the sell-off.

Bitinfocharts data reveals retail growth: addresses holding 0–0.1 DOGE rose to 2.94 million (from 2.89 million), and 0.1–1 DOGE wallets climbed to 785,001, up from 781,310 last week. 

Read Next: 

·         Bitcoin Falls Below $109,000, Ethereum, XRP, Dogecoin Can’t Catch A Break

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Why did Ethereum drop over 11% in just one week? Here's what spooked crypto investors, and why some bulls might see opportunity in the price drop.

The Ethereum (ETH 4.35%) cryptocurrency fell 11.3% since last Friday's closing bell, according to data from S&P Global Market Intelligence. This drop, recorded at 12:20 p.m. ET on Sept. 26, also dropped other Ethereum-based assets such as the iShares Ethereum Trust (ETHA 3.52%) exchange-traded fund (ETF) and the Wrapped Ethereum (WETH 4.26%) ERC-20 token by an identical amount.

This week's price drops on Ethereum and its tightly related alternatives came in two parts: a wave of profit-taking at the end of last weekend, followed by a discouraging inflation report on Thursday.

As a reminder, the iShares Ethereum ETF reflects Ethereum's price moves by design, and Wrapped Ethereum is just a parcel of Ethereum coins wrapped in a smart contract (also on the Ethereum blockchain) for easy programmatic access. These assets will always stay close to the underlying Ethereum chart, which is why the whole trio is down by identical amounts this week.

Two punches knocked Ethereum down this week
Ethereum is a rather volatile cryptocurrency, even in comparison to other names in digital assets. As such, it's sensitive to macroeconomic trends.

This week's report of August's inflation rates showed higher price increases than expected, and may result in a tighter fiscal policy in upcoming months. That could divert the Federal Reserve from the interest rate cuts it recently signaled, which in turn would be bad news for volatile investments -- such as Ethereum and friends.

When interest rates on new debt are high, institutional investors turn away from risky bets. And institutional interest has been a leading catalyst for Ethereum's growth since the iShares fund and other Ether-based ETFs were launched in the summer of 2024.

It's a macroeconomic domino effect, with very real impacts on the crypto sector.

Image source: Getty Images.

Ethereum still looks pretty good when you zoom out
That's not the end of Ethereum as we know it, though. Despite recent price corrections, this cryptocurrency has nearly doubled in six months, and it trades 174% above April's 52-week lows.

Ethereum bulls could see this price drop as a buying opportunity. I have seen some early signs of Web3 apps reaching large user groups (though the users may not realize there's any crypto tech involved), likely setting the stage for widespread Ethereum use in 2026 and beyond.

Anders Bylund has positions in Ethereum and iShares Ethereum Trust - iShares Ethereum Trust ETF. The Motley Fool has positions in and recommends Ethereum. The Motley Fool has a disclosure policy.

Firm honored with this distinction for the second time

, /PRNewswire/ -- Bernstein Private Wealth Management (Bernstein), a unit of AllianceBernstein L.P. (NYSE: AB), announced today that for the second time its Global Families team has been honored with the Financial Advisor Team of the Year award at the 2025 Society for Trusts & Estate Practitioners (STEP) Private Client Awards. This prestigious accolade recognizes the firm's unparalleled expertise in cross-border wealth management and its commitment to solving complex wealth needs of ultra-high-net-worth (UHNW) clients.

"We are truly honored to be recognized by STEP as Financial Advisor Team of the Year," said Shelly Meerovitch, Co-Head of Global Families at Bernstein. "This award is a testament to our deep commitment to helping UHNW global families with the highest level of expertise and care. Navigating cross-border wealth and complexity requires a sophisticated and personalized approach, and we are proud to partner with our clients serving as their trusted advisor through every challenge and opportunity."

Bernstein was recognized by a team of judges for the Financial Advisor Team of the Year Award for its outstanding work with UHNW clients, recognizing how it guides families with complex cross-border challenges with skill and care. The firm was also selected for its next-generation education, bespoke offshore investment platforms and ground-breaking research as well as ethical practice and focus on long-term client and peer relationships. Bernstein also achieved this award in 2021.

Christopher Opie, Managing Director of Global Families at Bernstein added, "We are honored by this recognition, which reflects the passion, dedication and specialized expertise of our team in managing some of the most complex cross-border issues global families face. From global tax planning to multijurisdictional governance, our work is about helping families to achieve their goals with confidence. We're thrilled that STEP has acknowledged the impact of our work with our clients." 

As part of the firm's award-winning UHNW platform, Global Families is a dedicated cross-border wealth advisory group with deep expertise in serving UHNW clients and their professional advisors. The team advises US and international families, business owners, family offices and more through complex tax, regulatory, and investment challenges—with integrated advice, modeling, and reporting across US and international platforms.

The STEP Private Client Awards recognize and celebrate excellence among private client solicitors, lawyers, accountants, barristers, bankers, trust managers and financial advisors. All entries undergo rigorous assessment by the Presiding Judges, an international panel of leading experts from across the industry. The winners were announced at the Awards Ceremony on September 18, 2025, at the London Hilton on Park Lane, UK. This year saw 337 entries from 25 countries. The full list of winners is available at: https://pca.step.org/winners-2025.

Bernstein has $144 billion in assets under management as of June 30, 2025.

About Bernstein Private Wealth Management

Bernstein Private Wealth Management advises ultrahigh- and high-net-worth clients on planning for—and living with—the complexities that come with significant wealth. Bernstein is distinguished among major wealth managers by its expertise in navigating life's transitions through a holistic approach. A flexible process—paired with innovative research, sophisticated modeling, and cutting-edge investment solutions—also set Bernstein apart. Headquartered in Nashville, TN, Bernstein is a business unit of AllianceBernstein, which ranks among the largest investment managers in the world, with offices in major world markets across 26 countries and jurisdictions and over $829 billion in assets under management as of June 30, 2025. For additional information, visit Bernstein.com.

About STEP

STEP is the global professional association for practitioners who specialize in family inheritance and succession planning. We have more than 22,000 members in 96 countries. STEP works to improve public understanding of the issues families face in this area and promotes education and high professional standards among its members. STEP members help families plan for their futures, from drafting wills to issues surrounding international families, protecting the vulnerable, family businesses and philanthropic giving. Find out more at www.step.org.

Media Contact: 
Katrina Clay 
[email protected]

SOURCE Bernstein Private Wealth Management

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Regions Financial (RF - Free Report) is headquartered in Birmingham, and is in the Finance sector. The stock has seen a price change of 13.1% since the start of the year. The holding company for Regions Bank is currently shelling out a dividend of $0.26 per share, with a dividend yield of 3.98%. This compares to the Banks - Southeast industry's yield of 2.29% and the S&P 500's yield of 1.54%.

Looking at dividend growth, the company's current annualized dividend of $1.06 is up 8.2% from last year. Over the last 5 years, Regions Financial has increased its dividend 4 times on a year-over-year basis for an average annual increase of 13.34%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Regions Financial's current payout ratio is 43%, meaning it paid out 43% of its trailing 12-month EPS as dividend.

Earnings growth looks solid for RF for this fiscal year. The Zacks Consensus Estimate for 2025 is $2.33 per share, which represents a year-over-year growth rate of 9.91%.

From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. However, not all companies offer a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, RF is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Headquartered in Tallahassee, Capital City Bank (CCBG - Free Report) is a Finance stock that has seen a price change of 15.99% so far this year. Currently paying a dividend of $0.26 per share, the company has a dividend yield of 2.45%. In comparison, the Banks - Southeast industry's yield is 2.29%, while the S&P 500's yield is 1.54%.

Looking at dividend growth, the company's current annualized dividend of $1.04 is up 18.2% from last year. Over the last 5 years, Capital City Bank has increased its dividend 5 times on a year-over-year basis for an average annual increase of 12.29%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Capital City Bank's current payout ratio is 28%, meaning it paid out 28% of its trailing 12-month EPS as dividend.

CCBG is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2025 is $3.43 per share, which represents a year-over-year growth rate of 9.94%.

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. It's important to keep in mind that not all companies provide a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. That said, they can take comfort from the fact that CCBG is not only an attractive dividend play, but also represents a compelling investment opportunity with a Zacks Rank of #2 (Buy).

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Headquartered in Pittsburgh, The PNC Financial Services Group, Inc (PNC - Free Report) is a Finance stock that has seen a price change of 5.13% so far this year. The company is paying out a dividend of $1.70 per share at the moment, with a dividend yield of 3.35% compared to the Financial - Investment Bank industry's yield of 0.92% and the S&P 500's yield of 1.54%.

Looking at dividend growth, the company's current annualized dividend of $6.80 is up 7.9% from last year. Over the last 5 years, The PNC Financial Services Group, Inc has increased its dividend 3 times on a year-over-year basis for an average annual increase of 8.49%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. The PNC Financial Services Group's current payout ratio is 44%, meaning it paid out 44% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, PNC expects solid earnings growth. The Zacks Consensus Estimate for 2025 is $15.57 per share, representing a year-over-year earnings growth rate of 11.93%.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. But, not every company offers a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, PNC is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.

Sonic Automotive (SAH - Free Report) is headquartered in Charlotte, and is in the Retail-Wholesale sector. The stock has seen a price change of 18.3% since the start of the year. Currently paying a dividend of $0.38 per share, the company has a dividend yield of 2.03%. In comparison, the Automotive - Retail and Whole Sales industry's yield is 0.22%, while the S&P 500's yield is 1.54%.

Looking at dividend growth, the company's current annualized dividend of $1.52 is up 21.6% from last year. Over the last 5 years, Sonic Automotive has increased its dividend 5 times on a year-over-year basis for an average annual increase of 33.71%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Sonic Automotive's current payout ratio is 22%, meaning it paid out 22% of its trailing 12-month EPS as dividend.

Earnings growth looks solid for SAH for this fiscal year. The Zacks Consensus Estimate for 2025 is $7.14 per share, with earnings expected to increase 27.50% from the year ago period.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. However, not all companies offer a quarterly payout.

High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, SAH presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #1 (Strong Buy).

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Based in Des Moines, Principal Financial (PFG - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 5.28%. Currently paying a dividend of $0.78 per share, the company has a dividend yield of 3.83%. In comparison, the Insurance - Multi line industry's yield is 1.65%, while the S&P 500's yield is 1.54%.

Looking at dividend growth, the company's current annualized dividend of $3.12 is up 9.5% from last year. Over the last 5 years, Principal Financial has increased its dividend 4 times on a year-over-year basis for an average annual increase of 5.97%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Principal Financial's current payout ratio is 40%, meaning it paid out 40% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, PFG expects solid earnings growth. The Zacks Consensus Estimate for 2025 is $8.28 per share, with earnings expected to increase 18.79% from the year ago period.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. However, not all companies offer a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, PFG presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Based in Chicago, Northern Trust Corporation (NTRS - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 28.18%. Currently paying a dividend of $0.80 per share, the company has a dividend yield of 2.44%. In comparison, the Banks - Major Regional industry's yield is 3.2%, while the S&P 500's yield is 1.54%.

Looking at dividend growth, the company's current annualized dividend of $3.20 is up 6.7% from last year. Over the last 5 years, Northern Trust Corporation has increased its dividend 1 times on a year-over-year basis for an average annual increase of 2.01%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Northern Trust's current payout ratio is 36%, meaning it paid out 36% of its trailing 12-month EPS as dividend.

NTRS is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2025 is $8.54 per share, which represents a year-over-year growth rate of 10.91%.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. However, not all companies offer a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, NTRS is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Based in Hong Kong, Lenovo Group Ltd. (LNVGY - Free Report) is in the Computer and Technology sector, and so far this year, shares have seen a price change of 15.46%. Currently paying a dividend of $0.76 per share, the company has a dividend yield of 5.09%. In comparison, the Computer - Micro Computers industry's yield is 2.85%, while the S&P 500's yield is 1.54%.

Looking at dividend growth, the company's current annualized dividend of $1.51 is up 59.3% from last year. Over the last 5 years, Lenovo Group Ltd. has increased its dividend 4 times on a year-over-year basis for an average annual increase of 0.23%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Lenovo Group's current payout ratio is 14%, meaning it paid out 14% of its trailing 12-month EPS as dividend.

LNVGY is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2025 is $2.43 per share, with earnings expected to increase 9.95% from the year ago period.

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, LNVGY presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Based in Little Rock, Bank OZK (OZK - Free Report) is in the Finance sector, and so far this year, shares have seen a price change of 16.42%. The bank is currently shelling out a dividend of $0.44 per share, with a dividend yield of 3.4%. This compares to the Banks - Northeast industry's yield of 2.55% and the S&P 500's yield of 1.54%.

Looking at dividend growth, the company's current annualized dividend of $1.76 is up 11.4% from last year. Over the last 5 years, Bank OZK has increased its dividend 5 times on a year-over-year basis for an average annual increase of 11.02%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Bank OZK's current payout ratio is 28%, meaning it paid out 28% of its trailing 12-month EPS as dividend.

Earnings growth looks solid for OZK for this fiscal year. The Zacks Consensus Estimate for 2025 is $6.36 per share, representing a year-over-year earnings growth rate of 3.58%.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. It's important to keep in mind that not all companies provide a quarterly payout.

High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, OZK presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).

Key Takeaways AbbVie projects revenue growth in 2025 despite Humira sales falling by over 54% in the first half of 2025.Skyrizi and Rinvoq are fueling gains with new launches, head-to-head data and expanding indications.AbbVie is also expanding in oncology and neuroscience, adding new drugs and boosting migraine uptake.
AbbVie (ABBV - Free Report) expects to return to robust revenue growth in 2025, despite the U.S. loss of exclusivity (LOE) for its flagship drug Humira over two years ago. The drug, which went off-patent in January 2023, saw first-half 2025 sales decline over 54% year over year to $2.3 billion. Humira had already lost exclusivity in ex-U.S. markets in 2018.

While the drug’s sales continue to face steep erosion, AbbVie’s ex-Humira portfolio has not only cushioned this blow but also helped position the company for a top-line rebound. This is primarily driven by the continued strength of its newer immunology drugs, Skyrizi and Rinvoq. The company successfully launched both drugs across Humira's major indications and a distinct new indication, atopic dermatitis. Skyrizi and Rinvoq have also demonstrated compelling head-to-head data against several novel therapies in clinical studies, giving them a competitive advantage.

Skyrizi and Rinvoq are seeing strong performance across all approved indications, especially in the popular inflammatory bowel disease (IBD) space, which includes two conditions, ulcerative colitis (UC) and Crohn’s disease (CD). Strong immunology market growth, market share gains and momentum from new indications, such as the recent launch of Skyrizi in UC, as well as the potential for five new indications for Rinvoq over the next few years, are expected to drive future growth. On the back of this continued momentum, AbbVie expects combined sales of both drugs to be more than $25 billion in 2025 and surpass $31 billion by 2027.

In addition to immunology, AbbVie has been expanding its presence in oncology and neuroscience. In recent years, ABBV has added Epkinly, Elahere and most recently, Emrelis, bringing its total oncology therapies to five. Growth in its neuroscience segment is also supported by increasing uptake of its migraine drugs, Ubrelvy and Qulipta.

ABBV’s Peers in the Immunology SpaceThe targeted market is highly competitive. A key player in the immunology market is Johnson & Johnson (JNJ - Free Report) , which markets two blockbuster drugs — Stelara and Tremfya. Both of these J&J medications are approved for multiple immunology indications, including UC and CD. Since Stelara lost U.S. patent exclusivity earlier this year, J&J has shifted focus to Tremfya to maintain its market position.

Another pharma giant expanding its presence in immunology is Eli Lilly (LLY - Free Report) , following the FDA approval of Omvoh for the UC indication in late 2023. Omvoh marked Lilly’s first immunology drug approved for a type of IBD in the United States, playing a key role in expanding its portfolio in this therapeutic area. The Lilly drug also received FDA approval for the CD indication in January.

ABBV’s Price Performance, Valuation and EstimatesShares of AbbVie have outperformed the industry year to date, as seen in the chart below.

Image Source: Zacks Investment Research

From a valuation standpoint, AbbVie is trading at a premium to the industry. Based on the price/earnings (P/E) ratio, the company’s shares currently trade at 15.86 times forward earnings, slightly higher than its industry’s average of 14.67. The stock is also trading above its five-year mean of 12.98.

Image Source: Zacks Investment Research

EPS estimates for 2025 and 2026 have increased in the past 60 days.

Image Source: Zacks Investment Research

AbbVie currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN JASPER THERAPEUTICS, INC. (JSPR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On July 7, 2025, Jasper released an update on its Phase 1b/2a clinical study of subcutaneous briquilimab for the treatment of Chronic Spontaneous Urticaria (“CSU”), referred to as the “BEACON Study,” stating that certain results “appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question,” and that Jasper was “taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing.” Further, the Company revealed it “has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma.” Jasper also disclosed that it would be “halting development in SCID” and “will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses.”

On this news, Jasper’s stock price fell $3.73, or 55.1%, to close at $3.04 per share on July 7, 2025, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (2) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company’s products, including briquilimab; (3) the foregoing increased the likelihood of disruptive cost-reduction measures; (4) accordingly, the Company’s business and/or financial prospects, as well as briquilimab’s clinical and/or commercial prospects, were overstated; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Jasper securities during the Class Period, you may move the Court no later than November 18, 2025 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements.

Contact Us To Participate or Learn More:

If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,

3070 Bristol Pike, Suite 112,

Bensalem, Pennsylvania 19020,

Telephone: (215) 638-4847

Email: [email protected],

Visit our website at: www.howardsmithlaw.com.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

More News From Law Offices of Howard G. Smith

Argentina's Economy Minister Luis Caputo participates in a business event, in Buenos Aires, Argentina, May 13, 2025. REUTERS/Agustin Marcarian/File Photo Purchase Licensing Rights, opens new tab

BUENOS AIRES, Sept 26 (Reuters) - Argentina has approved Canadian miner McEwen Copper's $2.7 billion Los Azules copper project in the country for a tax break program known as the Large Investment Incentive Regime (RIGI), the nation's economy minister said on Friday.

The project is set to contribute $1.1 billion in exports a year, Economy Minister Luis Caputo said in a post on X. McEwen Copper is a subsidiary of McEwen Mining

(MUX.TO), opens new tab.

Sign up here.

Argentina has not produced copper since its Alumbrera mine closed in 2018, but developers and analysts hope projects like Los Azules could make the South American nation a major global supplier.

Caputo said the approval marked a first for a copper mining proposal in San Juan province - Argentina's leading gold mining region and a hub for so far non-operational copper projects - and would directly and indirectly create over 3,500 jobs.

Los Azules is the eighth project to be approved for the RIGI tax break scheme, bringing a total investment of $15.7 billion under the incentive plan promoted by the government of libertarian President Javier Milei.

Company sources told Reuters McEwen estimates the total investment for Los Azules, which towers 3,500 meters above sea level in the Andes mountain range, will reach $3 billion over three to four years.

The company must now seek financing for this investment, they said.

McEwen plans to produce copper cathodes in Argentina starting from 2029, and should soon publish a feasibility study showing operational details for the next 20 years while in the meantime it works to secure permits.

The mine is set to use a leaching copper extraction method rather than the traditional method of floating and skimming the concentrate, which the company expects will allow it to use five-sixths less water and reduce the impact on local residents.

McEwen is Los Azules' main shareholder with a 46.4% stake, while automaker Stellantis

(STLAM.MI), opens new tab holds another 18.3% and Nuton/Rio Tinto

(RIO.AX), opens new tab owns 17.2%.

Reporting by Lucila Sigal; Editing by Sarah Morland

Our Standards: The Thomson Reuters Trust Principles., opens new tab

SAN FRANCISCO, Sept. 26, 2025 (GLOBE NEWSWIRE) -- A securities class action styled, Hernandez v. RCI Hospitality Holdings, Inc., et al., No. 4:25-cv-04477 (S.D. Tex.), has been filed after New York Attorney General James announced an indictment of RCI, CEO (Eric Langan), CFO (Bradley Chhay) and others of 79 crimes, including conspiracy, bribery, and criminal tax fraud. The lawsuit seeks to represent investors who invested in RCI Hospitality Holdings, Inc. (NASDAQ: RICK) securities December 15, 2021 and September 16, 2025.

The indictment and severe market reaction has prompted national shareholders rights firm Hagens Berman to continue its investigation into whether RCI may intentionally have misled investors about its adherence to laws, sufficiency of internal controls, and adherence to applicable accounting rules.

The firm urges investors in RCI who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Class Period: Dec. 15, 2021 – Sept. 16, 2025.
Lead Plaintiff Deadline: Nov. 20, 2025
Visit: www.hbsslaw.com/investor-fraud/rick
Contact the Firm Now: [email protected]
                                       844-916-0895

RCI Hospitality Holdings, Inc. (RICK) Securities Class Action:

The litigation is focused on the propriety of RCI’s repeated assurances that its financial statements complied with applicable accounting rules and that its internal controls over financial reporting were sufficient. These include the company’s assurances that “[w]e have developed comprehensive policies aimed at ensuring that the operation of each of our nightclubs is conducted in conformance with local, state, and federal laws.”

The complaint alleges that RCI made false and misleading statements while failing to disclose crucial information to investors. More specifically it alleges that RCI engaged in tax fraud, committed bribery to cover up the scheme, and understated the legal risks it faced.

Investors learned the truth on September 16, 2025, when NYAG James announced that the office indicted RCI, CEO Eric Langan, CFO Bradley Chhay and others. James said “[a]n investigation by the Office of the Attorney General (‘OAG’) revealed that RCI executives bribed an auditor with the New York Department of Taxation and Finance (‘DTF’) to avoid paying over $8 million in sales taxes to New York State and the state from 2010 to 2024.” The 79 count indictment charges RCI, five of its executives, and three RCI-owned strip clubs in Manhattan with conspiracy, bribery, and criminal tax fraud among other crimes.

On this news, the price of RCI shares declined almost 16% on September 16, 2025.

“We’re focused on investors’ losses and whether RCI may have intentionally misled investors about its compliance with relevant anti-bribery requirements, adherence to relevant accounting rules, and the sufficiency of internal controls,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in RCI and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the RCI case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding RCI should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Contact:
Reed Kathrein, 844-916-0895

Enbridge's stable cash flow model and consistent dividends contrast with Kinder Morgan's LNG-linked growth outlook.

, /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it placed No. 182 out of 400 companies listed on the 2025 Report on Business ranking of Canada's Top Growing Companies, with a three-year revenue growth rate of 188%.

This follows the Company's 2024 ranking of 87th out of 417 companies, with a three-year growth rate of 486%.

"For the fifth consecutive year, High Tide has been recognized by Report on Business as one of Canada's Top Growing Companies. This achievement reflects our team's hard work, the loyalty of our Cabana Club members, and the strength of our value-focused retail model," said Raj Grover, Founder and Chief Executive Officer of High Tide.

"While this recognition highlights the success of our Canadian operations to date, the recent closing of our majority acquisition of Remexian marks the beginning of an exciting new chapter for High Tide. By entering Europe's largest cannabis market, this expansion will enhance our revenue profile, broaden our international footprint, and create new opportunities for long-term growth. As always, I extend my deepest gratitude to our entire team for continuing to drive value creation across everything we do," added Mr. Grover.

Canada's Top Growing Companies is an editorial ranking that was launched in 2019 to celebrate the achievements of innovative businesses in Canada. To qualify for this voluntary program, companies had to complete an in-depth application process and fulfill revenue requirements. In total, 400 companies earned a spot on this year's ranking. The full list of 2025 winners along with editorial coverage is published in the October issue of Report on Business magazine. The list is also published online here.

"Our annual ranking of Canada's Top Growing Companies reflects the sector- spanning ingenuity of this country's entrepreneurs and corporate leaders," says Dawn Calleja, Editor of Report on Business magazine. "And we think it's important to tell their stories, to help inspire the next generation of up-and-comers across the country."

ABOUT REPORT ON BUSINESS

Report on Business magazine is the trusted source for business leaders and ambitious Canadians making a difference. With a monthly readership of 2.7 million across print and digital, Report on Business is the premier magazine for leaders across industries, corporations, start-ups, and small businesses.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 210 current locations across British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada. 

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: our ability of the Remexian acquisition to enhance our revenue profile, broaden our international footprint, and create new opportunities for long-term growth. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
[email protected]
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
[email protected]

SOURCE High Tide Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Analyst’s Disclosure:I/we have a beneficial long position in the shares of XLK, NVDA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

watch now

When Hou Yujie isn't convincing customers to rent traditional Chinese clothing for photos at the country's famous Forbidden City, she and her friends are checking stocks.

Hou recently put 10% of her money in the market. In just a few days, she earned one month's salary — and she's thrilled. 

"Interest rates for bank deposits are so low I don't even want to bother," Hou said at her shop outside the Beijing tourist site. "Stocks are a hot topic right now."

Chinese stocks, once deemed univestable by many, are luring both local and foreign investors impressed by recent returns. The Shanghai Composite hit a decade high earlier this month. Hong Kong's Hang Seng index is also up 30% in 2025, on pace for its biggest annual advance since 2017 — when it soared nearly 36%.

Stock Chart IconStock chart icon

Shanghai Composite since 2015

Government signals are encouraging investors to jump in.  

"There is a change of policy intention because of the deflationary pressure is getting more and more prominent," said Hao Hong, CIO at Lotus Asset Management. "The policymakers felt that they need to do something to refocus the government work on economic growth rather than minimize risk."

Chinese investors date the start of the rally, nicknamed the "9.24 performance," to Sept. 24, 2024 — when the country's central bank governor and other top financial chiefs held a rare coordinated press briefing, announcing measures to support the economy and the stock market.

The authorities held a similar media briefing Monday, declaring China's capital markets are expanding their "circle of friends" thanks to renewed interest by overseas investors.

For the first time in four years, Cathie Wood's Ark Investment Management funds reopened positions this week in Alibaba, according to a daily trading report.

The government is also trying to push in more institutional money to make Chinese markets a store of wealth like U.S. stocks. Regulators have mandated insurers and state mutual funds-- traditionally on the sidelines— to increase their holdings of equities.

Not only are Chinese retail investors taking cues from the government. They also have few other investment options.

Retail investor pushAfter a massive stock crash a decade ago, ordinary Chinese citizens have generally been wary of putting money in the stock market because they have been burned. But with the property sector in a protracted slump and restrictions on investments outside the country still tight, more are looking at the stock market again. Easing tensions in the U.S.-China trade war and Chinese progress in AI and chips have also boosted sentiment.

"AI and drones have been developing fast in China. I hear there is great potential for those stocks," Hou said.

But transforming the mindset of everyday Chinese still could take a while.

"Many of the retail investors still believe that it's a gamble. It's a casino. No one believes that it's a long term investment. It's very different from the U.S.," Hong said.

Unlike in the U.S. where retail investors account for about 20% of trade, China's average investors drive 90% of daily trading, according to HSBC data.

That means the Chinese stock boom could quickly turn to bust.

"As soon as I hear or sense the market going down, I'll grab my money and run for my life," Hou laughed.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Key Takeaways Eli Lilly won EU marketing approval for Kisunla to treat early symptomatic Alzheimer's disease.The approval was backed by TRAILBLAZER studies showing Kisunla slowed cognitive and functional decline.The FDA also clears Inluriyo for ER , HER2- breast cancer with ESR1 mutations after prior endocrine therapy.
Eli Lilly and Company (LLY - Free Report) announced that the European Commission (EC) has granted marketing authorization to Kisunla (donanemab) for the treatment of early symptomatic Alzheimer's disease (AD).

Kisunla is now approved in the European Union for treating early symptomatic AD in adults with mild cognitive impairment (MCI), as well as those with the mild dementia stage of AD, with confirmed amyloid pathology who are apolipoprotein E (ApoE4) heterozygotes or non-carriers.

The EU nod was based on data from two late-stage studies, TRAILBLAZER-ALZ 2 and TRAILBLAZER-ALZ 6.

Data from the phase III TRAILBLAZER-ALZ 2 study showed that treatment with Kisunla significantly slowed cognitive and functional decline. The dosing will be based on the phase IIIb TRAILBLAZER-ALZ 6 study.

Per management, treatment with Kisunla slows disease progression, which may help patients in preserving cognitive function and independence longer.

The FDA approved Kisunla for treating early symptomatic AD last year. The drug is also approved in Japan, China, the United Kingdom and several other countries.

LLY’s Price PerformanceYear to date, shares of Eli Lilly have declined 7.4% compared with the industry’s decrease of 0.5%.

Image Source: Zacks Investment Research

Marketed Drugs in the AD SpaceBesides Kisunla, another drug approved by the FDA in the AD space is Leqembi, which is developed by Biogen (BIIB - Free Report) /Eisai and was initially approved by the FDA in 2023. Leqembi is also approved in the European Union.

Both Biogen/Eisai’s Leqembi and Lilly’s Kisunla are approved to treat early symptomatic AD, which includes mild cognitive impairment or the dementia stage of the disease. The Biogen/Eisai and Lilly drugs are based on similar mechanisms, reducing the accumulation of amyloid beta (Aβ) plaque in the brain. Aβ is a protein that is said to be the primary cause of the cognitive decline associated with AD.

Alzheimer’s disease is a devastating neurodegenerative disorder characterized by the accumulation of tau tangles and amyloid beta (Aβ) plaques in the brain. Donanemab is an Aβ targeting therapy. Aβ is a protein that is said to be the primary cause of the cognitive decline associated with AD.

LLY’s Kisunla has been experiencing a rapid uptake. In the first half of 2025, Kisunla recorded sales worth $70.1 million as the new drug saw a steady launch trajectory.

LLY Gets FDA Nod for InluriyoIn a separate press release, Eli Lilly announced that the FDA has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for a breast cancer indication.

The regulatory body in the United States approved Inluriyo (200 mg tablets) for treating adult patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–), ESR1-mutated advanced or metastatic breast cancer whose disease progressed after at least one line of endocrine therapy.

The company plans to launch Inluriyo in the United States in the coming weeks.

The latest FDA nod was based on data from the phase III EMBER-3 study. Data from the same showed that treatment with Inluriyo monotherapy reduced the risk of progression or death by 38% compared to in patients with ESR1 mutations.

Notably, the Inluriyo label contains a warning and precaution for embryo-fetal toxicity.

Inluriyo is also being evaluated in the phase III EMBER-4 study in the adjuvant setting for treating patients with ER+, HER2– early breast cancer.

LLY’s Zacks Rank & Stocks to ConsiderEli Lilly currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the biotech sector are Akero Therapeutics (AKRO - Free Report) and Adaptive Biotechnologies (ADPT - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

In the past 60 days, estimates for Akero Therapeutics’ 2025 loss per share have narrowed from $3.93 to $3.74. Loss per share estimates for 2026 have narrowed from $4.27 to $4.12 during the same period. AKRO stock has surged 66.1% year to date.

Akero Therapeutics’ earnings beat estimates in three of the trailing four quarters while missing the same on the remaining occasion, the average surprise being 49.24%.

In the past 60 days, estimates for Adaptive Biotechnologies’ 2025 loss per share have narrowed from 87 cents to 71 cents. Loss per share estimates for 2026 have narrowed from 65 cents to 60 cents during the same period. ADPT stock has soared 119% year to date.

Adaptive Biotechnologies’ earnings beat estimates in each of the trailing four quarters, the average surprise being 23.99%.

As announced in a press release on July 30, 2025, Wendel will pay an interim dividend of €1.50 per share for the 2025 financial year. The payment schedule is as follows:

ex-dividend date: November 18, 2025record date : November 19, 2025payment date: November 20, 2025 The balance of the dividend for fiscal year 2025 will be submitted for approval at the next Shareholders’ Meeting, to be held on May 21, 2026.

Agenda

Jeudi 23 octobre 2025

Activité du T3 2025 – Publication de l’ANR au 30 septembre 2025 (après bourse)

Vendredi 12 décembre 2025

Investor Day 2025

Mercredi 25 février 2026

Résultats annuels 2025 – Publication de l’ANR au 31 décembre 2025, et comptes annuels consolidés (après bourse)

Mercredi 22 avril 2026

Chiffre d’affaires T1 2026 – Publication de l’ANR au 31 mars 2026 (après bourse)

Jeudi 21 mai 2026

Assemblée générale

Mercredi 29 juillet 2026

Résultats semestriels 2026 – Publication de l’ANR au 30 juin 2026 et comptes semestriels consolidés (après bourse)

À propos de Wendel

Wendel SE est l’une des toutes premières sociétés d’investissement cotées en Europe. Dans le cadre de son activité d’investissement pour compte propre, elle investit dans des sociétés leaders dans leur secteur : ACAMS, Bureau Veritas, Crisis Prevention Institute, Globeducate, IHS Towers, Scalian, Stahl et Tarkett. En 2023, Wendel a annoncé son intention de développer une plateforme de gestion d'actifs privés pour compte de tiers en complément de ses activités d'investissement pour compte propre. Dans ce cadre, Wendel a finalisé les acquisitions de 51 % d’IK Partners en mai 2024, et de 72 % de Monroe Capital en mars 2025. Au 30 juin 2025, le Groupe gère 39 Mds d’euros pour le compte d’investisseurs tiers, et environ 6,2 Mds d’euros investis pour compte propre.

Wendel est cotée sur l’Eurolist d’Euronext Paris.

Notation attribuée par Standard & Poor’s : Long terme : BBB avec perspective stable - Court terme : A-2 depuis le 25 janvier 2019.

Wendel est le Mécène Fondateur du Centre Pompidou-Metz. En raison de son engagement depuis de longues années en faveur de la Culture, Wendel a reçu le titre de Grand Mécène de la Culture en 2012

Pour en savoir plus : wendelgroup.com

Suivez-nous sur LinkedIn @Wendel 

Press contacts  Analyst and investor contacts Christine Anglade: +33 6 14 04 03 87          Olivier Allot: +33 1 42 85 63 73 [email protected] [email protected]
 
  Caroline Decaux: +33 1 42 85 91 27              Lucile Roch: +33 1 42 85 63 72 [email protected]    [email protected]
 
  Primatice
  Olivier Labesse: +33 6 79 11 49 71
  [email protected]
  Hugues Schmitt: +33 6 71 99 74 58
  [email protected]
 
 
  Kekst CNC
  Todd Fogarty: +1 212 521 4854
  [email protected]
 

CP - Acompte sur dividende 2025_26092025

LOS ANGELES--(BUSINESS WIRE)--Charter Communications, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CHTR.

GlobalFoundries could be in line to receive more orders if the Trump administration's plan to boost U.S. chip manufacturing comes to fruition.